Hepatocellular carcinoma and macrovascular tumor thrombosis: treatment outcomes and prognostic factors for survival

ConclusionsAlthough most patients with HCC and MTT showed disease progression, median survival time was significantly longer than that with supportive care. Main branch and  >  1 segment involvement of MTT and presence of ascites were significant prognostic factors for poor survival. Combined local and systemic therapy over systemic therapy alone are recommended for patients with these advanced stage HCCs.
Source: Japanese Journal of Radiology - Category: Radiology Source Type: research